Avidea Technologies (United States)

Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens

Geoffrey M. Lynn, Christine Sedlik, Faezzah Baharom et al. · Nature Biotechnology · 2020 · 322 citations · Full text

Vaccination, Nanomedicine, Cross-protection +12

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells

Faezzah Baharom, Ramiro A. Ramirez-Valdez, Kennedy K.S. Tobin et al. · Nature Immunology · 2020 · 197 citations · Full text

Vaccination, Nanomedicine, Engineering +8

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

Wilton B. Williams, Robert Meyerhoff, Robert J. Edwards et al. · Cell · 2021 · 88 citations · Full text

Immunocytochemical Technique, Autoimmune Disease, Glycosylation +12

Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates

Joseph R. Francica, Richard Laga, Geoffrey M. Lynn et al. · PLoS Biology · 2019 · 38 citations · Full text

Cyclotriphosphazene-Based Star Copolymers as Structurally Tunable Nanocarriers with Programmable Biodegradability

Ladislav Androvič, Lucie Woldřichová, Klaudia Jozefjaková et al. · Macromolecules · 2021 · 18 citations